REG - GlaxoSmithKline PLC - Director/PDMR Shareholding

GSKAnnouncement

16/04/2019 17:40

RNS Number : 4071W
GlaxoSmithKline PLC
16 April 2019
 


GlaxoSmithKline plc (the 'Company')
 
Transaction notification
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr B McNamara




b)


Position/status


CEO, GSK Consumer Healthcare




c)


Initial notification/
amendment


Initial notification




2.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 




a)


Description of the financial instrument


American Depositary Shares ('ADSs')
 
ISIN: US37733W1053
 




b)


Nature of the transaction


Acquisition of ADSs following the re-investment of dividends paid to shareholders on 11 April 2019 on shares held in the Deferred Annual Bonus Plan Post-Tax.




c)


Price(s) and volume(s)






Price(s)


Volume(s)




$40.8259


33.216








d)


Aggregated information
 
Aggregated volume Price
 


n/a (single transaction)




e)


Date of the transaction
 


2019-04-12




f)


Place of the transaction
 


New York Stock Exchange (XNYS)




 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQQLFFKZFXBBL